GSK Buys Affinivax for Up to $3.3B in Vaccine Push : compare

The agreement includes an upfront payment of $2.1 billion and two potential development milestones.

Related Keywords

Boston , Massachusetts , United States , Hal Barron , Gsk Plc , Affinivax Inc , Sierra Oncology , Scientific Officer Hal Barron , Elliott Investment Management , Bloomberg Intelligence ,